Contact
Angela Rossetti, D.Bioethics, M.B.A., is an adjunct assistant professor at New York Medical College. A biopharmaceutical industry veteran, she has worked in the industries of commercial development, global marketing, and advertising for over 30 years. She currently conducts consultations with biopharmaceutical companies, advising them on the intersection of science, business, and ethics.
She is a board member of Aethlon Medical, Inc., a medical device company dedicated to developing products to treat cancer and life-threatening infectious diseases, now in clinical trials in Australia.
Dr. Rossetti has previously held a board seat for companies in women’s health and rare diseases and with Danske Bank, advising on their biotech funds. She was a Global Vice President in Commercial Development at Pfizer and held several positions in marketing at Wyeth. She served as a strategic consultant to Kala Pharmaceuticals and Celgene Corporation before its acquisition by Bristol Myers Squibb. Dr. Rossetti was Executive Vice President at Cell Machines, Inc., an early-stage biopharmaceutical company developing novel protein therapies for hemophilia.
Education
- Doctorate of Bioethics (D.Bioethics), Loyola University Chicago
- M.S., Bioethics, Albert Einstein College of Medicine/Cardozo Law School
- M.B.A., General Management and Finance, Columbia University
- B.A., Dual Major in Biology and English, University of Pennsylvania
Areas of Expertise
- Pharmaceutical Ethics
- Rare Disease Ethics
- Research Ethics
- Narrative Ethics
Research
- Doctoral Concentration in Research Ethics
Professional Service
- Biopharmaceutical Industry Consultations
- Rare Disease Company Consultations
- Secular Ethics for Catholic Institutions
Memberships and Affiliations
- Empire State Bioethics Consortium
- Biopharmaceutical Industry Bioethics Forum (Charter Member)
Teaching Responsibilities
- Medical Ethics
- Pharmaceutical Ethics
- Rare Disease Ethics
- Secular Ethics
